Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 32, 2002 - Issue 1
119
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Biotransformation of benzydamine by microsomes and precision-cut slices prepared from cattle liver

, , , , &
Pages 73-86 | Published online: 22 Sep 2008

References

  • BALDOCK, G. A., BRODIE, R. R., CHASSEAUD, L. F., TAYLOR, T., WALMSLEY, L. M. and CATANESE, B., 1991, Pharmacokinetics of benzydamine after intravenous, oral, and topical doses to human subjects. Biopharmaceutics and Drug Disposition, 12, 481–492.
  • BAAR, J., WEIR, A. J., BRENDEL, K. and SIPES, I. G., 1991, Liver slices in dynamic organ culture, an alternative in vitro technique for the study of rat hepatic drug metabolism. Xenobiotica, 21, 331–339.
  • BICKEL, M. H., 1969, The pharmacology and biochemistry of N-oxides. Pharmacological Review, 21, 325–355.
  • BLAKE B. L., ROSE, L. R., MAILMAN, R. B., LEVI, P. E. and HODGSON, E., 1995, Metabolism of thioridazine by microsomal monooxygenases: relative roles of P450 and flavin-countering monooxygenases. Xenobiotica, 25, 377–393.
  • CINU, S. L. and HUSKEY, S. W., 1998, Species differences in N-glucuronidation. Drug Metabolism and Disposition, 26, 838–847.
  • COLDHAM, N., MOORE, A. S., DAVE, M., GRAHAM, P. J., SIVAPATHASUNDARAM, S., LAKE, B. G. and SAUER, M. J., 1995, Imidocarb residues in edible bovine tissues and in vitro assessment of imidocarb metabolism and cytotoxicity. Drug Metabolism and Disposition, 23, 501–505.
  • DAIN, J. G., NICOLETTI, J. and BALLARD, F., 1997, Biotransformation of clozapine in humans. Drug Metabolism and Disposition, 25, 603–609.
  • DOGTEROM, P., 1993, Development of a simple incubation system for metabolism studies with precision-cut liver slices. Drug Metabolism and Disposition, 21, 699–704.
  • GEORGE, E., MURDOCK, J., AYLOTT, M. and WESTMORELAND, C., 1999, Comparison of hepatocyte cultures and liver slices in vitro toxicity testing. Alternatives to Laboratory Animals, 27, 769–781.
  • HAWES, E. M., 1998, N+-glucuronidation, a common pathway in human metabolism of drugs with a tertiary amine group. Drug Metabolism and Disposition, 26, 830–837.
  • KAIBAF, M., SEPAI, O. and LAMB, J. H., 1992, Identification of metabolites of 4,4'-diaminodiphenylmethane (methylene dianiline) using liquid chromatographic and mass spectrometric techniques. Journal of Chromatography Biomedical Application, 583, 63–76.
  • KATAOKA, S., Nano, T., NISHIMURA, K. and TAIRA, K., 1979b, Effect of carrageenin treatment on the metabolism of benzydamine and its N-oxide in rat organ preparations. Chemical and Pharmaceutical Bulletin, 27, 2904–2912.
  • KATAOKA, S., NISHIMURA, K. and NAITO T., 1 979a, In vivo metabolism and anti-inflammatory activity of benzydamine hydrochloride in rats treated with carrageenin. Chemical and Pharmaceutical Bulletin, 27, 2890-2903.
  • KATAOKA, S., TAIRA, K., ARIYOSHI, T. and TAKABATAK E., 1973, Metabolism of benzydamine hydrochloride: species differences and the identification of unconjugated metabolites in rabbit urine. Chemical and Pharmaceutical Bulletin, 21, 358–365.
  • KATAOKA, S., TAIRA, K. and TAKABATAK E., 1971, Metabolism of benzydamine hydrochloride. Chemical and Pharmaceutical Bulletin, 19, 1511–1513.
  • KAWAJI, A., OHARA, K. and TAKABATAK E., 1993, An assay of flavin-containing monooxygenase activity with benzydamine N-oxidation. Analytical Biochemistry, 214, 409–412.
  • KAWAJI, A., OHARA, K. and TAKABATAK E., 1994, Determination of flavin-containing monooxygenase activity in rat brain microsomes with benzydamine N-oxidation. Biological and Pharmaceutical Bulletin, 17, 603–606.
  • KOPPEL, C. and TENCZER, J., 1985, Metabolism of benzydamine. Arzneimittel-ForschunglDrug Research, 35, 634–635.
  • LOWRY, O. H., ROSEBROUGH, N. J., FAR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 293, 265–275.
  • LUO, H., HAWES, E. M., McKAv, G., KORCHINSKI, E. D. and MIDHA, K. K., 1995, N+ glucuronidation of aliphatic tertiary amines in human: antidepressant versus antipsychotic drugs. Xenobiotica, 25, 291–301.
  • MAGGS, J. L., PIRMOHAMED, M., KITTERINGHAM, N. R. and PARK, B. K., 1997, Characterization of the metabolites of carbamazepine in patient urine by liquid chromatography/mass spectrometry. Drug Metabolism and Disposition, 25, 275–280.
  • MILLER, M. G., BEYER, J., HALL, G. L., DEGRAFFENRIED, L. and ADAMS, P. E., 1993, Predictive value of liver slices for metabolism and toxicity in vivo: use of acetaminophen as a model hepatotoxicant. Toxicology and Applied Pharmacology, 122, 108–116.
  • MONTESISSA, C., ANFOSSI, P., BIANcorro, G. and ANGELETTI, R., 1998, In vitro metabolism of clenbuterol and bromobuterol by pig liver microsomes. Xenobiotica, 28, 1049–1060.
  • OMURA, T. and SATo, R., 1964, The carbon monoxide binding pigment of liver microsomes. Journal of Biological Chemistry, 239, 2370–2378.
  • SAYLERS, K. L., BARR, J. and SIPES, I. G., 1994, In vitro metabolism of theophylline by rat and human liver tissue. Xenobiotica, 24, 389–399.
  • SMITH, P. F., FISHER, R., SHUBAT, P. J., GANDOL, V. J., KRUMDIECK, C. L. and BRENDEL, K., 1987, In vitro cytotoxicity of allyl alcohol and bromobenzenes in novel organ culture system. Toxicology and Applied Pharmacology, 87, 509–522.
  • UBEAUD, G., SCHILLER, C. L., HURBIN, F., JAECK, D. and COASSOLO, P., 1999, Estimation of fiavin-containing monooxygenase activity in intact hepatocyte monolayers of rat, hamster, rabbit, dog and human by using N-oxidation of benzydamine. European Journal of Pharmaceutical Sciences, 8, 255–260.
  • ZIEGLER, D. M., 1988, Flavin-containing monooxygenases: catalytic mechanism and substrate specificities. Drug Metabolism Review, 19, 1–32.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.